Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3EV3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,467.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors. This competitively awarded, firm fixed-price contract with no set-aside designation was issued on December 17, 2025, with an ultimate completion date of January 9, 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a specialty pharmaceutical used in the treatment of inflammatory skin conditions, reflecting the Defense Logistics Agency's ongoing need to supply specialized medications to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor contract running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's status as a major pharmaceutical distributor and critical vendor for federal medical procurement, combined with its competitive track record on DLA contracts, positions it to fulfill specialized pharmaceutical needs across the defense healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26F3EV3?
SPE2DR26F3EV3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F3EV3 worth?
The government has obligated $12,467 on SPE2DR26F3EV3.
Is contract SPE2DR26F3EV3 an order under another contract?
Yes. SPE2DR26F3EV3 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3EV3 competed?
The extent of competition for SPE2DR26F3EV3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award